TARDBP and amyotrophic lateral sclerosis: Amyotrophic lateral sclerosis (ALS) is characterized pathologically by loss of upper and lower motor neurons with consistent occurrence of phosphorylated TDP-43 (pTDP-43)-immunoreactive neuronal and glial inclusions in the central nervous system [2, 15].